Skip to main content
SpringerLink
Log in

Candida: Some Thoughts

  • Conference paper
Yearbook of Intensive Care and Emergency Medicine 2000

Part of the book series: Yearbook of Intensive Care and Emergency Medicine ((YEARBOOK,volume 2000))

Abstract

Candida infection as a local problem is well recognized in the normal population but even more commonly encountered in populations with impaired immune responses and increased susceptibility to Candida colonization. There is a gradation of colonization from that which is asymptomatic, through symptomatic, and at the far end of the spectrum the septicemic version of the disease. Paradoxically the complexity of diagnosis increases with the severity of the disease such that Candida septicemia is difficult to diagnose.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Alexander JW, Boyce ST, Babcock GF, et al (1990) The process of microbial translocation. Ann Surg 212: 496–510

    Article  PubMed  CAS  Google Scholar 

  2. Berg R, Bernasconi P, Fowler D, Gautreaux M (1993) Inhibition of Candida albicans translocation from the gastrointestinal tract of mice by oral administration of Saccharomyces boulardii. J Infect Dis 168: 1314–1318

    Article  PubMed  CAS  Google Scholar 

  3. Damjanovic V, Connolly CM, van Saene HK, et al (1993) Selective decontamination with nystatin for control of a Candida outbreak in a neonatal intensive care unit. J Hosp Infect 24: 245–259

    Article  PubMed  CAS  Google Scholar 

  4. Inoue S, Peck MD, Alexander JW (1991) Fungal translocation is associated with increased mortality after thermal injury in guinea pigs. J Burn Care Rehabil 12: 19–22

    Article  PubMed  CAS  Google Scholar 

  5. Wells CL (1990) Relationship between intestinal microecology and the translocation of intestinal bacteria. Antonie Van Leeuwenhoek 58: 87–93

    Article  PubMed  CAS  Google Scholar 

  6. Jarvis WR, Martone WJ (1992) Predominant pathogens in hospital infections. J Antimicrob Chemother 29: 19–24

    Article  PubMed  Google Scholar 

  7. Jarvis WR (1995) Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin Infect Dis 20: 1526–1530

    Article  PubMed  CAS  Google Scholar 

  8. Harvey RL, Myers JP (1987) Nosocomial fungemia in a large community teaching hospital. Arch Intern Med 147: 2117–2120

    Article  PubMed  CAS  Google Scholar 

  9. Anaissie E, Bodey GP (1989) Nosocomial fungal infections. Old problems and new challenges. Infect Dis Clin North Am 3: 867–882

    Google Scholar 

  10. Beck Sague C, Jarvis WR (1993) Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980–1990. National Nosocomial Infections Surveillance System. J Infect Dis 167: 1247–1251

    Google Scholar 

  11. Morrison AJ Jr, Freer CV, Searcy MA, Landry SM, Wenzel RP (1986) Nosocomial bloodstream infections: secular trends in a statewide surveillance program in Virginia. Infect Control 7: 550–553

    PubMed  Google Scholar 

  12. Pfaller M, Wenzel R (1992) Impact of the changing epidemiology of fungal infections in the (1990s. Eur J Clin Microbiol Infect Dis 11: 287–291

    Article  PubMed  CAS  Google Scholar 

  13. Safran DB, Dawson E (1997) The effect of empiric and prophylactic treatment with fluconazole on yeast isolates in a surgical trauma intensive care unit. Arch Surg 132: 1184–1189

    Article  PubMed  CAS  Google Scholar 

  14. Wingard JR, Merz WG, Rinaldi MG, Johnson TR, Karp JE, Saral R (1991) Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med 325: 1274–1277

    Article  PubMed  CAS  Google Scholar 

  15. Abi Said D, Anaissie E, Uzun O, Raad I, Pinzcowski H, Vartivarian S (1997) The epidemiology of hematogenous candidiasis caused by different Candida species. Clin Infect Dis 24: 1122–1128

    Article  Google Scholar 

  16. Plouffe JF, Brown DG, Silva J Jr, Eck T, Stricof RL, Fekety FR Jr (1977) Nosocomial outbreak of Candida parapsilosis fungemia related to intravenous infusions. Arch Intern Med 137: 1686–1689

    Article  PubMed  CAS  Google Scholar 

  17. Huang YC, Lin TY, Peng HL, Wu JH, Chang HY, Leu HS (1998) Outbreak of Candida albicans fungaemia in a neonatal intensive care unit. Scand J Infect Dis 30: 137–142

    Article  PubMed  CAS  Google Scholar 

  18. Huang YC, Lin TY, Leu HS, Peng HL, Wu JH, Chang HY (1999) Outbreak of Candida parapsilosis fungemia in neonatal intensive care units: clinical implications and genotyping analysis. Infection 27: 97–102

    Article  PubMed  CAS  Google Scholar 

  19. Pfaller MA (1994) Epidemiology and control of fungal infections. Clin Infect Dis 19 (suppl 1): S8 - S13

    Article  PubMed  Google Scholar 

  20. Solomkin JS, Flohr AM, Simmons RL (1982) Indications for therapy for fungemia in postoperative patients. Arch Surg 117: 1272–1275

    Article  PubMed  CAS  Google Scholar 

  21. Krcmery V Jr, Spanik S, Grausova S, et al (1998) Candida parapsilosis fungemia in cancer patients–incidence, risk factors and outcome. Neoplasma 45: 336–342

    Google Scholar 

  22. Nolla-Salas J, Sitges-Serra A, Leon-Gil C, et al (1997) Candidemia in non-neutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy. Study Group of Fungal Infection in the ICU. Intensive Care Med 23: 23–30

    Google Scholar 

  23. Pittet D, Tarara D, Wenzel RP (1994) Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA 271: 1598–1601

    Google Scholar 

  24. Pittet D, Wenzel RP (1995) Nosocomial bloodstream infections. Secular trends in rates, mortality, and contribution to total hospital deaths. Arch Intern Med 155: 1177–1184

    Google Scholar 

  25. Wenzel RP (1995) Nosocomial candidemia: risk factors and attributable mortality. Clin Infect Dis 20: 1531–1534

    Article  PubMed  CAS  Google Scholar 

  26. Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP (1988) Hospital-acquired candidemia. The attributable mortality and excess length of stay. Arch Intern Med 148: 2642–2645

    Google Scholar 

  27. Palmer DL (1984) Microbiology of pneumonia in the patient at risk. Am J Med 76: 53–60

    Article  PubMed  CAS  Google Scholar 

  28. el Ebiary M, Torres A, Fabregas N, et al (1997) Significance of the isolation of Candida species from respiratory samples in critically ill, non-neutropenic patients. An immediate postmortem histologic study. Am J Respir Crit Care Med 156: 583–590

    Google Scholar 

  29. Pittet D, Monod M, Suter PM, Frenk E, Auckenthaler R (1994) Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 220: 751–758

    Google Scholar 

  30. Barzotta A, Beardsley K (1999) Candida infection in critically ill trauma patients) a retrospective case-control study. Arch Surg 134: 657–664

    Google Scholar 

  31. Solomkin J, Flohr A, Quie P, Simmons R (1980) The role of Candida in intraperitoneal infections. Surgery 88: 524–530

    PubMed  CAS  Google Scholar 

  32. British S, for Antimicrobial Chemotherapy Working Party (1994) Management of deep Candida infection in surgical and intensive care unit patients. Intensive Care Med 20: 522–528

    Google Scholar 

  33. Nolla Salas J, Leon C, Torres Rodriguez JM, Martin E, Sitges Serra A (1992) Treatment of candidemia in critically ill surgical patients with intravenous fluconazole. Clin Infect Dis 14: 952–954

    Article  Google Scholar 

  34. Odds FC, Vranckx L, Woestenborghs F (1995) Antifungal susceptibility testing of yeasts: evaluation of technical variables for test automation. Antimicrob Agents Chemother 39: 2051–2060

    Article  PubMed  CAS  Google Scholar 

  35. Morace G, Sanguinetti M, Posteraro B, Pagano L (1995) In vitro susceptibility of Candida species isolated from patients with haematological malignancies. Mycoses 38: 59–67

    Article  PubMed  CAS  Google Scholar 

  36. Rodero LL, Davel GO, Vivot W, Canteros CE, Fernandez C (1995) In vitro sensitivity tests for yeasts: evaluation of a micromethod. Rev Argent Microbiol 27: 81–89

    PubMed  CAS  Google Scholar 

  37. Schmalreck AF, Kottmann I, Reiser A, Ruffer U, Scharr E, Vanca E (1995) An evaluation of seven methods of testing in vitro susceptibility of clinical yeast isolates to fluconazole. Mycoses 38: 359–368

    Article  PubMed  CAS  Google Scholar 

  38. Wanger A, Mills K, Nelson PW, Rex JH (1995) Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for antifungal susceptibility testing: enhanced ability to detect amphotericin B-resistant Candida isolates. Antimicrob Agents Chemother 39: 2520–2522

    Article  PubMed  CAS  Google Scholar 

  39. Maenza JR, Keruly JC, Moore RD, Chaisson RE, Merz WG, Gallant JE (1996) Risk factors for fluconazole-resistant candidiasis in human immunodeficiency virus-infected patients. J Infect Dis 173: 219–225

    Article  PubMed  CAS  Google Scholar 

  40. Manso E, Montillo M, Discepoli G, Leoni P (1991) Fluconazole resistance of Candida krusei. Boll Ist Sieroter Milan 70: 527–529

    PubMed  Google Scholar 

  41. Marr KA, White TC, van Burik JA, Bowden RA (1997) Development of fluconazole resistance in Candida albicans causing disseminated infection in a patient undergoing marrow transplantation. Clin Infect Dis 25: 908–910

    Article  PubMed  CAS  Google Scholar 

  42. Sanglard D, Kuchler K, Ischer F, Pagani JL, Monod M, Bille J (1995) Mechanisms of resistance to azote antifungal agents in Candida albicans isolates from AIDS patients involve specific multi-drug transporters. Antimicrob Agents Chemother 39: 2378–2386

    Article  PubMed  CAS  Google Scholar 

  43. Tumbarello M, Tacconelli E, Caldarola G, Morace G, Cauda R, Ortona L (1997) Fluconazole resistant oral candidiasis in HIV-infected patients. Oral Dis 3: S110 - S112

    PubMed  Google Scholar 

  44. Smith LG (1986) Fungal nosocomial superinfection. N Engl J Med 83: 597–598

    CAS  Google Scholar 

  45. Cerra F, Maddaus M, Dunn D, et al (1992) Selective gut decontamination reduces nosocomial infections and length of stay but not mortality or organ failure in surgical intensive care unit patients. Arch Surg 127: 163–169

    Article  PubMed  CAS  Google Scholar 

  46. Desai M, Rutan R, Heggers J, Herndon D (1992) Candida infection with and without nystatin prophylaxis. Arch Surg 127: 159–162

    Google Scholar 

  47. Savino J, Agarwal N, Wry P, Policastro A, Cerabona T, Austria L (1994) Routine prophylactic anti-fungal agents (clotrimazole, ketoconazole, and nystatin) in non transplant, non burned, critically ill surgical and trauma patients. J Trauma 36: 20–26

    Article  PubMed  CAS  Google Scholar 

  48. Lo WK, Chan CY, Cheng SW, Poon JF, Chan DT, Cheng IK (1996) A prospective randomized control study of oral nystatin prophylaxis for Candida peritonitis complicating continuous ambulatory peritoneal dialysis. Am J Kidney Dis 28: 549–552

    Article  PubMed  CAS  Google Scholar 

  49. Lumbreras C, Cuervas Mons V, Jara P, et al (1996) Randomized trial of fluconazole versus nystatin for the prophylaxis of Candida infection following liver transplantation. J Infect Dis 174: 583–588

    Article  PubMed  CAS  Google Scholar 

  50. Ninane J (1994) A multicentre study of fluconazole versus oral polyenes in the prevention of fungal infection in children with hematological or oncological malignancies. Multicentre Study Group. Eur J Clin Microbiol Infect Dis 13: 330–337

    Article  PubMed  CAS  Google Scholar 

  51. Milliken ST, Powles RL (1990) Antifungal prophylaxis in bone marrow transplantation. Rev Infect Dis 12: 5374–5379

    Article  Google Scholar 

  52. Alvarez Alvarez ME, Sanchez Sousa A, Baquero F (1998) A reevaluation of nystatin in prophylaxis and treatment of oropharyngeal candidiasis. Rev Esp Quimioter 11: 295–315

    Google Scholar 

  53. Janknegt R, de Marie S, Bakker-Woudenberg I, Crommelin D (1992) Liposomal and lipid formulations of amphotericin B. Clin Pharmacokinet 23: 279–291

    Article  PubMed  CAS  Google Scholar 

  54. Anaissie EJ, Vartivarian SE, Abi Said D, et al (1996) Fluconazole versus amphotericin B in the treatment of hematogenous candidiasis: a matched cohort study. Am J Med 101: 170–176

    Article  PubMed  CAS  Google Scholar 

  55. Abele Horn M, Kopp A, Sternberg U, et al (1996) A randomized study comparing fluconazole with amphotericin B/5-flucytosine for the treatment of systemic Candida infections in intensive care patients. Infection 24: 426–432

    Article  Google Scholar 

  56. Martino P, Girmenia C (1997) Are we making progress in antifungal therapy? Curr Opin Oncol 9: 314–320

    Article  PubMed  CAS  Google Scholar 

  57. Adler-Moore J, Proffitt R (1993) Development characterization efficacy and mode of action of Ambisome, a unilamellar liposomal formulation of amphotericin B. J Liposomal Res 3: 429–450

    Article  CAS  Google Scholar 

  58. Mehta RT, Poddar S, Kalidas M, Gomez Flores R, Dulski K (1997) Role of macrophages in the candidacidal activity of liposomal amphotericin B. J Infect Dis 175: 214–217

    Article  PubMed  CAS  Google Scholar 

  59. Ralph ED, Barber KR, Grant CW (1991) Liposomal amphotericin B: an effective, nontoxic preparation for the treatment of urinary tract infections caused by Candida albicans. Am J Nephrol 11: 118–122

    Article  PubMed  CAS  Google Scholar 

  60. Ralph ED, Khazindar AM, Barber KR, Grant CW (1991) Comparative in vitro effects of liposomal amphotericin B, amphotericin B-deoxycholate, and free amphotericin B against fungal strains determined by using MIC and minimal lethal concentration susceptibility studies and time-kill curves. Antimicrob Agents Chemother 35: 188–191

    Article  PubMed  CAS  Google Scholar 

  61. Lister J (1996) Amphotericin B lipid complex (Abelcet) in the treatment of invasive mycoses: the North American experience. Eur J Haematol 56 (suppl 57): 18–23

    Article  Google Scholar 

  62. White MH, Bowden RA, Sandler ES, et al (1998) Randomized, double-blind clinical trial of amphotericin B colloidal dispersion vs. amphotericin B in the empirical treatment of fever and neutropenia. Clin Infect Dis 27: 296–302

    Article  PubMed  CAS  Google Scholar 

  63. Herbrecht R (1997) Safety of amphotericin B colloidal dispersion. Eur J Clin Microbiol Infect Dis 16: 74–80

    Article  PubMed  CAS  Google Scholar 

  64. de Marie S (1996) Liposomal and lipid-based formulations of amphotericin B. Leukemia 10: S93 - S96

    CAS  Google Scholar 

  65. Noskin GA, Pietrelli L, Coffey G, Gurwith M, Liang LJ (1998) Amphotericin B colloidal dispersion for treatment of candidemia in immunocompromised patients. Clin Infect Dis 26: 461–467

    Article  PubMed  CAS  Google Scholar 

  66. Anaissie EJ, Mattiuzzi GN, Miller CB, et al (1998) Treatment of invasive fungal infections in renally impaired patients with amphotericin B colloidal dispersion. Antimicrob Agents Chemother 42: 606–611

    PubMed  CAS  Google Scholar 

  67. Oppenheim BA, Herbrecht R, Kusne S (1995) The safety and efficacy of amphotericin B colloidal dispersion in the treatment of invasive mycoses. Clin Infect Dis 21: 1145–1153

    Article  PubMed  CAS  Google Scholar 

  68. Nicolau DP, Crowe H, Nightingale CH, Quintiliani R (1995) Bioavailability of fluconazole administered via a feeding tube in intensive care unit patients. J Antimicrob Chemother 36: 395–401

    Article  PubMed  CAS  Google Scholar 

  69. Desai MH, Rutan RL, Heggers JP, Herndon DN (1992) Candida infection with and without nystatin prophylaxis. A 11-year experience with patients with burn injury. Arch Surg 127: 159–162

    Google Scholar 

  70. Gupta TP, Ehrinpreis MN (1990) Candida-associated diarrhea in hospitalized patients. Gastroenterology 98: 780–785

    PubMed  CAS  Google Scholar 

  71. Dube MP, Heseltine PN, Rinaldi MG, Evans S, Zawacki B (1994) Fungemia and colonization with nystatin-resistant Candida rugosa in a burn unit. Clin Infect Dis 18: 77–82

    Article  PubMed  CAS  Google Scholar 

  72. Sheridan RL, Weber JM, Budkevich LG, Tompkins RG (1995) Candidemia in the pediatric patient with burns. J Burn Care Rehabil 16: 440–443

    Article  PubMed  CAS  Google Scholar 

  73. Slotman G, Burchard K (1987) Ketoconazole prevents Candida sepsis in critically ill surgical patients. Arch Surg 122: 147–151

    Article  PubMed  CAS  Google Scholar 

  74. Girmenia C, Martino P, Cassone A (1996) Breakthrough candidemia during antifungal treatment with fluconazole in patients with hematologic malignancies. Blood 87: 838–839

    PubMed  CAS  Google Scholar 

  75. Le Guennec R, Reynes J, Mallie M, Pujol C, Janbon F, Bastide JM (1995) Fluconazole-and itraconazole-resistant Candida albicans strains from AIDS patients: multilocus enzyme electrophoresis analysis and antifungal susceptibilities. J Clin Microbiol 33: 2732–2737

    PubMed  CAS  Google Scholar 

  76. Wingard JR, Merz WG, Rinaldi MG, Miller CB, Karp JE, Saral R (1993) Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients. Antimicrob Agents Chemother 37: 1847–1849

    Article  PubMed  CAS  Google Scholar 

  77. Epstein JB, Ransier A, Lunn R, et al (1996) Prophylaxis of candidiasis in patients with leukemia and bone marrow transplants. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 81: 291–296

    Article  PubMed  CAS  Google Scholar 

  78. Eggiman P, Francioli P, Schneider R, et al (1999) Fluconazole prophylaxis prevents intra-abdominal candidiasis in high risk surgical patients. Crit Care Med 27: 1066–1072

    Article  Google Scholar 

  79. Rex 1 (1996) Catheters and candidemia. Clin Infect Dis 22: 467–469

    Article  PubMed  CAS  Google Scholar 

  80. Rex J, Bennett J, Sugar A, et al (1994) A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. N Engl J Med 331: 1325–1330

    Article  PubMed  CAS  Google Scholar 

  81. Nguyen MH, Peacock JE Jr, Tanner DC, et al (1995) Therapeutic approaches in patients with candidemia. Evaluation in a multicenter, prospective, observational study. Arch Intern Med 155: 2429–2435

    Google Scholar 

  82. Graninger W, Presteril E, Schneeweiss B, Teleky B, Georgopoulos A (1993) Treatment of Candida albicans fungaemia with fluconazole. J Infect 26: 133–146

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. N. Soni
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Erasme Hospital, Free University of Brussels, Route de Lennik 808, B-1070, Brussels, Belgium

    Jean-Louis Vincent (Head Department of Intensive Care) (Head Department of Intensive Care)

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Soni, N. (2000). Candida: Some Thoughts. In: Vincent, JL. (eds) Yearbook of Intensive Care and Emergency Medicine 2000. Yearbook of Intensive Care and Emergency Medicine, vol 2000. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-13455-9_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-13455-9_13

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-66830-5

  • Online ISBN: 978-3-662-13455-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation